Investment Considerations HealthLynked Corp. is a pioneering healthcare technology company revolutionizing patient care through innovative digital solutions. Dr. Michael T. Dent, CEO and Chairman, leads the company with a significant history of successful healthcare management and technology development; his prior leadership at NeoGenomics Laboratories, a company with a current market cap of approximately $2 billion, … Continue reading “HealthLynked Corp. (OTCQB: HLYK)”